STE Stock Analysis: Buy, Sell, or Hold?
STE - STERIS plc
$218.20
5.90 (2.78%)
▲
5d:
+3.61%
30d:
+4.02%
90d:
-0.79%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When STE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: STE shows positive signals but monitor for confirmation. Market pricing in 2.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: STE shows positive signals but monitor for confirmation. Market pricing in 2.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$321.60
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$199.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STE is currently trading at $218.20, which is considered extended relative to its 30-day fair value range of $205.17 to $214.42. The stock's valuation (Forward PE: 19.7) is in line with its historical norms (21.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This pessimistic expectation contrasts with the company's recent 52.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STE is in a strong downtrend. The price is approaching resistance at $218.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $256.86 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STE is in a strong downtrend. The price is approaching resistance at $218.66. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $256.86 (+17.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$205.17 -
$214.42
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($256.86)
Trading Range Analysis
30-Day Trading Range
$205.17 -
$214.42
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$8.52
(3.9%)
Support & Resistance Levels
Support Level
$198.94
Resistance Level
$218.66
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.70
Wall Street Target
$256.86
(+17.7%)
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
52.2%
Profit Margin
13.2%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
19.7 vs 21.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$212.09
(-3%)
2-Year Target
$206.15
(-6%)
3-Year Target
$200.38
(-8%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$217.72
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.6%)
$309.19
(+42%)
Base:
(SPY PE: 19.7, Growth: 8.6%)
$279.60
(+28%)
Bear:
(PE: 16.7, Growth: 8.6%)
$237.66
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.74 | Current EPS (TTM): $7.94
Bull Case
$325.85
(+49%)
Analyst growth 39.5%, PE expands to 29.4
Base Case
$296.22
(+36%)
Market implied 39.5%, PE stable at 26.7
Bear Case
$144.36
(-34%)
Severe decline -20.0%, PE contracts to 22.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.7 to 21.4
Stabilization Target:
$237.09
(+8.7%)
PE Expansion Potential:
+8.7%
Share & Embed Analysis
Last updated: July 03, 2026 8:28 PM ET
Data refreshes hourly during market hours. Next update: 9:28 PM
Data refreshes hourly during market hours. Next update: 9:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STE showing a specific setup today?
Insider Activity (6 Months)
4
Buys
4
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
April McClain Delaney
BUY
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
Advanced STE Option Strategies
Professional options setups generated by AI based on today's STE price and gamma walls.
